Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov;15(11):713-718.

Comparison of Chlamydia trachomatis infection among infertile and fertile women in Ahvaz, Iran: A case-control study

Affiliations
Free PMC article

Comparison of Chlamydia trachomatis infection among infertile and fertile women in Ahvaz, Iran: A case-control study

Fatemeh Joolayi et al. Int J Reprod Biomed. 2017 Nov.
Free PMC article

Abstract

Background: Chlamydia trachomatis (C. trachomatis) is the main cause of bacterial sexually transmitted infections. In women, this infection can lead to tubal infertility.

Objective: In this study we investigated C. trachomatis among infertile and fertile women with both polymerase chain reaction (PCR) and ELISA methods in Ahvaz, Iran.

Materials and methods: This case-control study was conducted at the Infertility Clinic of University Jahad, Ahvaz, Iran from January to August 2017. A total of 225 vaginal swabs and blood samples (100 infertile and 125 fertile women) were collected. Detection of C. trachomatis DNA was performed from vaginal swabs by amplification of MOMP gene. Also, anti C. trachomatis immunoglobulin M (IgM) and immunoglobulin G antibodies in the serum samples were recognized by enzyme-linked immunosorbent assay (ELISA).

Results: Results showed that, 6 (6%) infertile and 2 (1.6%) fertile women were positive for IgM (p=0.21). Also, PCR was positive for C. trachomatis infection in 5 infertile (5%) and 2 fertile women (1.6%) (p=0.35). We did not find any seropositive immunoglobulin G in both groups.

Conclusion: In this study, no significant difference was found between fertile and infertile groups for C. trachomatis infection. Also, the correlation between IgM and PCR results revealed a relatively strong agreement and seems both PCR and IgM assays are appropriate for the accurate diagnosis of C. trachomatis infections.

Keywords: C. Trachomatis; IgG; IgM; Infertility; PCR.

Conflict of interest statement

There isn’t any conflict of interest among the authors.

Figures

Figure 1
Figure 1
The amplification of C. trachomatis by PCR. L: size marker of 100 bp, lanes 1 to 6: Positive samples for C. trachomatis; lane 7: positive control, lane 8: negative control

Similar articles

Cited by

References

    1. Weinstock H, Berman S, Cates WJr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36:6–10. - PubMed
    1. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted diseases: overview and estimates. WHO/GPA/STD/95. Geneva: 1995.
    1. Miller KE. Diagnosis and treatment of Chlamydia trachomatis infection. Am Fam Physician. 2006;73:1411–1416. - PubMed
    1. Mardh PA. Tubal factor infertility, with special regard to Chlamydial salpingitis. Curr Opin Infect Dis. 2004;17:49–52. - PubMed
    1. Svensson LO, Mares I, Olsson SE, Nordström ML. Screening for Chlamydia trachomatis infection in women and aspects of the laboratory diagnostics. Acta Obstet Gynecol Scand. 1991;70:587–590. - PubMed

LinkOut - more resources